Dr. Lasky-Su is an Associate Professor in Medicine at Brigham and Women’s Hospital and Harvard Medical School. She earned her doctoral degree in Genetic Epidemiology from Harvard School of Public Health and has spent the last 19 years focusing on the identification of genetic, genomic, and metabolomic determinants for complex diseases. The accumulation of these efforts has resulted in over 100 peer-reviewed original research manuscripts. Dr. Lasky-Su’s more recent work has focused on analytic and network approaches to integrate metabolomics and other omics data types with the end goal of making strides towards precision medicine. She is currently the principal investigator and co-investigator on many grants focused on the integration of metabolomics and other omics data types for several diseases including asthma, allergies, preeclampsia, macular degeneration, cancer, and several other complex diseases. Dr. Lasky-Su currently serves in leadership capacities in a variety of consortiums, including acting as the chairman of the Consortium of METabolomic Studies (COMETS). Through this consortium, she has worked with other COMETs investigators to facilitate the utilization of metabolomics in large population-based cohorts. Her long-term goals is to continue to promote metabolomics research among the epidemiological community through the establishment of solid statistical approaches, the harmonization of data, and the integration of metabolomics or other omics data.